Antiplaque Claims Spectrum Outlined By WhiteHill
This article was originally published in The Rose Sheet
Executive Summary
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA